FDA Inspection
Prothya Biosolutions Netherlands B.V.Prothya Biosolutions Netherlands B.V. – FDA Inspection, Nov 20, 2014
Record Details
This FDA Inspection record concerns Prothya Biosolutions Netherlands B.V., with an inspection on November 20, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- November 20, 2014
- Product Type
- Biologics
View Company Profile
ID · 3b7af2f8-afcc-4f9f-bc35-22aa3a72c00a
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 906173
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Prothya Biosolutions Netherlands B.V.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 13, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 4, 2013 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 28, 2011 | OAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 15, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Prothya Biosolutions Netherlands B.V.
- FDA Inspection 1046705 - 2018-03-30
- FDA Inspection 969120 - 2016-05-13
- FDA Inspection 835110 - 2013-06-04
- FDA Inspection 748170 - 2011-09-28
- FDA Inspection 620661 - 2009-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.